Fatty acid oxidation disorders: a new class of metabolic diseases.
about
Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhoodPurification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patientsImpact of fatty acid oxidation disorders in child neurology: from Reye syndrome to Pandora's boxCloning of human very-long-chain acyl-coenzyme A dehydrogenase and molecular characterization of its deficiency in two patientsMetabolic disease in the fetus predisposes to maternal hepatic complications of pregnancyMaternal acute fatty liver of pregnancy associated with fetal trifunctional protein deficiency: molecular characterization of a novel maternal mutant alleleA novel mitochondrial carnitine-acylcarnitine translocase induced by partial hepatectomy and fastingOxygenation by COX-2 (cyclo-oxygenase-2) of 3-HETE (3-hydroxyeicosatetraenoic acid), a fungal mimetic of arachidonic acid, produces a cascade of novel bioactive 3-hydroxyeicosanoidsInborn errors of mitochondrial fatty acid oxidation.Two alpha subunit donor splice site mutations cause human trifunctional protein deficiencyThe molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancyMedium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.Levocarnitine and dialysis: a review.Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.Persistent neonatal hypoglycemia: Diagnosis and management.Connexin- and pannexin-based channels in normal skeletal muscles and their possible role in muscle atrophy.Successful Treatment of Cardiomyopathy due to Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: First Case Report from Oman with Literature Review.Metabolic enzymes dysregulation in heart failure: the prospective therapy.Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders.Organic acidurias and related abnormalities.A lethal neonatal phenotype of mitochondrial short-chain enoyl-CoA hydratase-1 deficiency.Mammalian mitochondrial beta-oxidation.Medium chain 3-ketoacyl-coenzyme A thiolase deficiency: a new disorder of mitochondrial fatty acid beta-oxidation.Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LKruppel-like factor 15 is required for the cardiac adaptive response to fasting.Mitochondrial short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: a new defect of fatty acid oxidation.A novel mouse model of X-linked cardiac hypertrophy.Polymorphic ventricular tachycardia and abnormal Ca2+ handling in very-long-chain acyl-CoA dehydrogenase null mice
P2860
Q24303615-1B025F8F-DB90-4514-BC6C-D4CA6C240A8EQ24628908-AC903ED8-7C72-474A-93B4-F7001E329A30Q28085372-825C9877-07A3-4EF2-BC24-3D71944B5B90Q28114930-ADFC1787-2B3B-48D5-A68D-897FBCC47EB6Q28142066-608F8410-73AD-4692-9F9B-F15A84A32F28Q28293444-85A596FF-A5D9-4880-A6FF-663A6739B6E7Q28586883-B58646CC-D73C-4ECD-928F-F1E255EE81C6Q33433330-AEB0DCCE-DDC5-42C4-8E55-5303C27B2475Q33875702-AEB94A96-E919-4EAA-A54D-5EDB490EE682Q34216105-B13D0731-862F-4D7B-AC90-7D690FCDF04FQ34723105-65BFC873-92A7-4E69-9CB7-26AD8A86926EQ35194087-6D8ADF81-79A3-4590-9A9F-4068215918B9Q36278353-E256C590-3D6B-46E4-8F08-D90737F56A87Q37575903-8DED06A8-F90B-4812-94F8-3A25DFD61C42Q37733273-0E373D46-5669-41FA-B246-445F7AC112DFQ38031128-60981963-C517-4AB8-9334-99EB91FA1493Q38138574-6BF4F852-8324-4A9E-9251-9A90B828CECCQ39011735-9A14316F-8E3D-42E4-A0B9-E0EE25EB79EAQ39155672-B21C7518-ECC1-45A8-9040-D8AFB290839DQ39426415-7B5C642C-2B83-4A03-9F73-E0A9477ED4AAQ40422979-C7514E3E-C4D4-40DC-BA83-CA0F38E1B76FQ40447579-1E12F2D3-FC9E-4FF4-8D4F-E5B19AEA4883Q41280085-ECC612BF-B3E1-4C40-BC6B-5E02DC34B989Q42546758-39015CAD-247F-416D-ABB1-FF9DE81C879EQ44350878-C9288AB2-37F6-4FEE-BD06-915A24CBE5CCQ48097578-9BA3C3DC-744A-4EA3-804E-B8C490DB001EQ51583597-6D42FD5F-CC01-4F69-A2A1-05660543C144Q51959136-921853D5-8EF9-477F-BE0C-981B3A6A76B1Q56744092-5FB59A87-C0EB-417A-A496-AD1C98C2415B
P2860
Fatty acid oxidation disorders: a new class of metabolic diseases.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Fatty acid oxidation disorders: a new class of metabolic diseases.
@ast
Fatty acid oxidation disorders: a new class of metabolic diseases.
@en
type
label
Fatty acid oxidation disorders: a new class of metabolic diseases.
@ast
Fatty acid oxidation disorders: a new class of metabolic diseases.
@en
prefLabel
Fatty acid oxidation disorders: a new class of metabolic diseases.
@ast
Fatty acid oxidation disorders: a new class of metabolic diseases.
@en
P1476
Fatty acid oxidation disorders: a new class of metabolic diseases.
@en
P2093
P356
10.1016/S0022-3476(05)82532-6
P407
P577
1992-07-01T00:00:00Z